411 related articles for article (PubMed ID: 12471124)
1. The activation and subsequent regulatory roles of Lyn and CD19 after B cell receptor ligation are independent.
Xu Y; Beavitt SJ; Harder KW; Hibbs ML; Tarlinton DM
J Immunol; 2002 Dec; 169(12):6910-8. PubMed ID: 12471124
[TBL] [Abstract][Full Text] [Related]
2. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
[TBL] [Abstract][Full Text] [Related]
3. CD19 amplification of B lymphocyte Ca2+ responses: a role for Lyn sequestration in extinguishing negative regulation.
Fujimoto M; Poe JC; Hasegawa M; Tedder TF
J Biol Chem; 2001 Nov; 276(48):44820-7. PubMed ID: 11584010
[TBL] [Abstract][Full Text] [Related]
4. Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22.
Bobbitt KR; Justement LB
J Immunol; 2000 Nov; 165(10):5588-96. PubMed ID: 11067914
[TBL] [Abstract][Full Text] [Related]
5. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes.
Chan VW; Lowell CA; DeFranco AL
Curr Biol; 1998 May; 8(10):545-53. PubMed ID: 9601638
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
Buhl AM; Cambier JC
J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
[TBL] [Abstract][Full Text] [Related]
7. A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice.
Hasegawa M; Fujimoto M; Poe JC; Steeber DA; Lowell CA; Tedder TF
J Immunol; 2001 Sep; 167(5):2469-78. PubMed ID: 11509585
[TBL] [Abstract][Full Text] [Related]
8. CD19 differentially regulates BCR signalling through the recruitment of PI3K.
Xu Y; Fairfax K; Light A; Huntington ND; Tarlinton DM
Autoimmunity; 2014 Nov; 47(7):430-7. PubMed ID: 24953501
[TBL] [Abstract][Full Text] [Related]
9. A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals.
Nishizumi H; Horikawa K; Mlinaric-Rascan I; Yamamoto T
J Exp Med; 1998 Apr; 187(8):1343-8. PubMed ID: 9547345
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of B cell receptor-mediated signaling in B-1 cells through CD5 and Ly49 co-receptors via Lyn kinase activity.
Ochi H; Watanabe T
Int Immunol; 2000 Oct; 12(10):1417-23. PubMed ID: 11007759
[TBL] [Abstract][Full Text] [Related]
11. CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction.
Poe JC; Hasegawa M; Tedder TF
Int Rev Immunol; 2001; 20(6):739-62. PubMed ID: 11913948
[TBL] [Abstract][Full Text] [Related]
12. Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop.
Fujimoto M; Bradney AP; Poe JC; Steeber DA; Tedder TF
Immunity; 1999 Aug; 11(2):191-200. PubMed ID: 10485654
[TBL] [Abstract][Full Text] [Related]
13. CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux.
Poe JC; Fujimoto M; Jansen PJ; Miller AS; Tedder TF
J Biol Chem; 2000 Jun; 275(23):17420-7. PubMed ID: 10748054
[TBL] [Abstract][Full Text] [Related]
14. CD22 regulates B cell receptor-mediated signals via two domains that independently recruit Grb2 and SHP-1.
Otipoby KL; Draves KE; Clark EA
J Biol Chem; 2001 Nov; 276(47):44315-22. PubMed ID: 11551923
[TBL] [Abstract][Full Text] [Related]
15. Signaling mutations and autoimmunity.
Yu CC; Mamchak AA; DeFranco AL
Curr Dir Autoimmun; 2003; 6():61-88. PubMed ID: 12408047
[TBL] [Abstract][Full Text] [Related]
16. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection.
Cornall RJ; Cyster JG; Hibbs ML; Dunn AR; Otipoby KL; Clark EA; Goodnow CC
Immunity; 1998 Apr; 8(4):497-508. PubMed ID: 9586639
[TBL] [Abstract][Full Text] [Related]
17. Syk, but not Lyn, recruitment to B cell antigen receptor and activation following stimulation of CD45- B cells.
Pao LI; Cambier JC
J Immunol; 1997 Mar; 158(6):2663-9. PubMed ID: 9058799
[TBL] [Abstract][Full Text] [Related]
18. B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.
Asano N; Fujimoto M; Yazawa N; Shirasawa S; Hasegawa M; Okochi H; Tamaki K; Tedder TF; Sato S
Am J Pathol; 2004 Aug; 165(2):641-50. PubMed ID: 15277237
[TBL] [Abstract][Full Text] [Related]
19. Reduced dosage of Bruton's tyrosine kinase uncouples B cell hyperresponsiveness from autoimmunity in lyn-/- mice.
Whyburn LR; Halcomb KE; Contreras CM; Lowell CA; Witte ON; Satterthwaite AB
J Immunol; 2003 Aug; 171(4):1850-8. PubMed ID: 12902486
[TBL] [Abstract][Full Text] [Related]
20. Activation of lyn, blk, and btk but not syk in CD72-stimulated B lymphocytes.
Venkataraman C; Muthusamy N; Muthukkumar S; Bondada S
J Immunol; 1998 Apr; 160(7):3322-9. PubMed ID: 9531290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]